Theriva Biologics, Inc. (TOVX)
0.2514
+0.01
(+2.57%)
USD |
NYAM |
Aug 31, 16:00
0.2514
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Cash from Operations (Annual) : -16.67M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -16.67M |
| December 31, 2024 | -16.94M |
| December 31, 2023 | -19.00M |
| December 31, 2022 | -19.08M |
| December 31, 2021 | -12.89M |
| December 31, 2020 | -12.17M |
| December 31, 2019 | -13.87M |
| December 31, 2018 | -17.28M |
| December 31, 2017 | -20.20M |
| December 31, 2016 | -27.90M |
| December 31, 2015 | -38.89M |
| December 31, 2014 | -16.08M |
| December 31, 2013 | -7.719M |
| December 31, 2012 | -8.916M |
| December 31, 2011 | -2.875M |
| December 31, 2010 | -1.140M |
| Date | Value |
|---|---|
| December 31, 2009 | -2.919M |
| December 31, 2008 | -4.852M |
| December 31, 2007 | -6.607M |
| December 31, 2006 | -2.366M |
| December 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| December 31, 2003 | -0.6246M |
| December 31, 2002 | -5.825M |
| December 31, 2001 | -8.067M |
| December 31, 2000 | -5.646M |
| December 31, 1999 | -16.14M |
| December 31, 1998 | -18.68M |
| December 31, 1997 | -6.677M |
| December 31, 1996 | -6.044M |
| December 31, 1995 | -7.542M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 127.04M |
| Nkarta, Inc. | -88.70M |
| Unicycive Therapeutics, Inc. | -31.32M |
| OnKure Therapeutics, Inc. | -51.83M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |